Pub. Date : 2010
PMID : 19900123
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The receptor tyrosine kinase (RTK) inhibitor imatinib mesylate has been approved as the first-line choice of therapy for this group of patients, while the RTK inhibitor, sunitinib malate, has been approved for the treatment of GIST after disease progression or intolerance to imatinib. | Sunitinib | ret proto-oncogene | Homo sapiens |